Thousands of skin cancer patients in England are set to benefit from fast-tracked access to a groundbreaking new cancer vaccine trial as part of a pioneering NHS programme. The trial, involving a DNA-based vaccine known as iSCIB1+ (Immunobody®), is being rolled out across multiple NHS hospitals under the Cancer Vaccine Launch Pad (CVLP) scheme. It … Continue reading Skin Cancer Patients in England to Get Fast-Tracked Access to ‘Revolutionary’ Vaccine Trial on the NHS